This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction Surgery

Sponsored by Artivion Inc.

About this trial

Last updated 2 years ago

Study ID

PHF1901.000-M (11/19)

Status

Terminated

Type

Observational

Placebo

No

Accepting

18-75 Years
All
All
All

Trial Timing

Ended 3 years ago

What is this trial about?

The objective of this postmarket, retrospective, single center study is to evaluate the clinical outcomes of patients who have received PhotoFix® Decellularized Bovine Pericardium (PhotoFix) as a patch within a cardiac surgical repair or reconstruction procedure. PhotoFix is prepared from bovine pericardium, which is stabilized using a dye-mediated photo-oxidation process and sterilized using aseptic processing techniques.

What are the participation requirements?

Yes

Inclusion Criteria

- Subject has undergone a cardiac procedure which falls within the indications for use and required the use of PhotoFix Decellularized Bovine Pericardium

No

Exclusion Criteria

- Subject required valve leaflet repair using PhotoFix

Locations

Location

Status